查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765170

全球腎臟去神經支配技術市場

Renal Denervation Technologies
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 107 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，全球腎臟去神經支配技術市場規模將達到 31 億美元

全球腎臟去神經支配技術市場規模預計在2024年達到3.783億美元，預計在分析期內（2024-2030年）將以41.7%的複合年成長率成長，到2030年將達到31億美元。射頻技術是本報告分析的細分市場之一，預計其複合年成長率將達到41.3%，到分析期結束時將達到21億美元。超音波技術細分市場在分析期間的複合年成長率預計為43.5%。

美國市場規模估計為 9,040 萬美元，中國市場預計複合年成長率為 51.7%

美國腎臟去神經支配技術市場規模預計2024年達到9,040萬美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到2.499億美元，在2024-2030年的分析期間內，複合年成長率為51.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為34.4%和38.0%。在歐洲，預計德國市場的複合年成長率約為38.4%。

全球腎臟去神經支配技術市場—主要趨勢與促進因素摘要

腎去神經支配技術是治療難治性高血壓的一項有希望的進展，難治性高血壓是指儘管使用多種抗高血壓藥物，高血壓仍然無法控制的疾病。這種微創手術涉及使用導管射頻或超音波能量來消融腎臟動脈周圍的腎神經。腎去神經支配旨在透過阻斷透過這些神經傳遞的訊號來減少交感神經系統活動並降低血壓。此手術通常在局部麻醉下進行，導管經由股動脈插入並引導至腎動脈進行標靶消融。這種手術不僅可以降低血壓，還顯示出產生持久益處的潛力，這使其成為傳統治療方法不夠有效的患者的理想選擇。

技術進步顯著提高了腎臟去神經支配術的療效和安全性。早期臨床試驗面臨結果不一致的挑戰，促使該技術進一步創新和改進。現代系統採用改良的導管設計，可提供更佳的導航和更精準的能量輸送，最大限度地減少對周圍組織的損傷，並改善患者預後。此外，影像和測繪技術的進步使得更精確地定位腎神經成為可能，從而實現有效消融。人們對非射頻方法（例如超音波和化學消融）的興趣也日益濃厚，這些方法各有優勢，提供了替代方法。持續的研究和發展正在加深我們對高血壓潛在生理機制的理解，並正在催生更有效、更個人化的腎臟去神經支配術策略。

腎臟去神經技術市場的成長受到多種因素的推動。全球高血壓盛行率的上升，尤其是難治性高血壓，是一個主要促進因素，因為它刺激了對創新治療方案的需求。醫療技術的進步和對高血壓病理生理學的深入了解，促進了更有效、更安全的腎臟去神經系統的發展。全球人口老化，加上不良飲食和久坐不動等生活方式因素，導致高血壓盛行率上升，進一步擴大了此類技術的潛在市場。此外，越來越多的臨床證據支持腎臟去神經的長期益處和安全性，正在鼓勵更多的醫療保健提供者採用這種治療方法。現代醫學推行微創手術，原因是患者偏好恢復期更短、併發症更少的治療方法，這也支持了市場的成長。這些因素共同凸顯了腎臟去神經技術市場的動態和快速發展。

部分

技術（基於射頻、基於超音波、基於微輸注）

受訪公司範例

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Otsuka Medical Devices Co., Ltd.
  • Ablative Solutions, Inc.
  • Mercator MedSystems, Inc.
  • Autonomix Medical

人工智慧整合

利用檢驗的專家內容和 AI 工具轉變您的市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 拉丁美洲
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP14407

Global Renal Denervation Technologies Market to Reach US$3.1 Billion by 2030

The global market for Renal Denervation Technologies estimated at US$378.3 Million in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 41.7% over the analysis period 2024-2030. Radiofrequency Based, one of the segments analyzed in the report, is expected to record a 41.3% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Ultrasound Based segment is estimated at 43.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$90.4 Million While China is Forecast to Grow at 51.7% CAGR

The Renal Denervation Technologies market in the U.S. is estimated at US$90.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$249.9 Million by the year 2030 trailing a CAGR of 51.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 34.4% and 38.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 38.4% CAGR.

Global Renal Denervation Technologies Market - Key Trends & Drivers Summarized

Renal denervation technologies represent a promising advancement in the treatment of resistant hypertension, a condition where high blood pressure remains uncontrolled despite the use of multiple antihypertensive medications. This minimally invasive procedure involves the use of catheter-based radiofrequency or ultrasound energy to ablate the renal nerves, which are located around the arteries leading to the kidneys. By disrupting the signals transmitted through these nerves, renal denervation aims to reduce sympathetic nervous system activity, thereby lowering blood pressure. The procedure is typically performed under local anesthesia and involves the insertion of a catheter through the femoral artery, guided to the renal arteries, where targeted ablation is conducted. The technique has shown potential not only in reducing blood pressure but also in offering sustained effects, making it an attractive option for patients who do not respond adequately to conventional therapies.

Technological advancements have significantly enhanced the efficacy and safety of renal denervation procedures. Early clinical trials faced challenges with inconsistent results, prompting further innovation and refinement in the technology. Modern systems now offer improved catheter designs with better navigability and precision in delivering energy, which minimizes damage to surrounding tissues and enhances patient outcomes. Additionally, advancements in imaging and mapping technologies allow for more accurate targeting of the renal nerves, ensuring effective ablation. There has also been a growing interest in non-radiofrequency methods, such as ultrasound and chemical ablation, which provide alternative approaches with their own unique benefits. Continuous research and development are expanding the understanding of the physiological mechanisms underlying hypertension, leading to more effective and tailored renal denervation strategies.

The growth in the renal denervation technologies market is driven by several factors. The increasing prevalence of hypertension worldwide, particularly resistant hypertension, is a major driver, as it fuels the demand for innovative treatment options. Advances in medical technology and a deeper understanding of the pathophysiology of hypertension have led to the development of more effective and safer renal denervation systems. The aging global population, coupled with lifestyle factors such as poor diet and sedentary behavior, contributes to the rising incidence of hypertension, further expanding the potential market for these technologies. Additionally, the growing body of clinical evidence supporting the long-term benefits and safety of renal denervation is encouraging more healthcare providers to adopt this treatment modality. The push for minimally invasive procedures in modern medicine, driven by patient preference for treatments with shorter recovery times and fewer complications, also supports market growth. These factors collectively highlight the dynamic and rapidly evolving nature of the renal denervation technologies market.

SCOPE OF STUDY:

The report analyzes the Renal Denervation Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Radiofrequency Based, Ultrasound Based, Micro-Infusion Based)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Otsuka Medical Devices Co., Ltd.
  • Ablative Solutions, Inc.
  • Mercator MedSystems, Inc.
  • Autonomix Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Renal Denervation Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Hypertension - A Chronic Disease
    • A Prelude to Renal Denervation
    • The Evolution
    • Global Renal Denervation Technologies Market Set to Witness Rapid Growth
    • Developed Regions Dominate, Asia-Pacific Exhibits Fastest Growth
    • Europe - A Major Market
    • Radiofrequency Ablation Dominates the Market, Ultrasound to Register Fastest Growth
    • Radiofrequency Based Renal Denervation
    • Ultrasound Based Renal Denervation
    • Micro-Infusion Based Renal Denervation
    • Stringent Regulatory Environment
    • Growth Deterrents
    • Competitive Landscape
    • Select List of Approved Renal Denervation Devices
    • Symplicity Renal Denervation System Leads
    • Renal Denervation Devices
    • EnligHTN
    • Iberis
    • Paradise
    • Symplicity
    • Vessix (V2)
    • Recent Market Activity
    • Recent Clinical Trials in Nerve Denervation Technologies
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Hypertension Drives the Market for Renal Denervation Technologies Market
    • Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
    • Ageing Demographics to Propel the Demand for Renal Denervation Devices
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Rising Obesity Incidence Spurs the Demand for Renal Denervation Technologies Market
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Uptrend in Healthcare Spending Creates Fertile Environment
    • Regulatory Approvals to Remain a Focal Point
    • Breakthrough Designations for Renal Denervation Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Renal Denervation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Radiofrequency Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Radiofrequency Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Ultrasound Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Micro-Infusion Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Micro-Infusion Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2025 & 2030
    • TABLE 9: World Renal Denervation Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 10: USA Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 11: USA 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • CANADA
    • TABLE 12: Canada Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 13: Canada 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • JAPAN
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 14: Japan Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Japan 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • CHINA
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 16: China Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 17: China 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • EUROPE
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 18: Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: Europe 6-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 20: Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Europe 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • FRANCE
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 22: France Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: France 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • GERMANY
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 24: Germany Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Germany 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • ITALY
    • TABLE 26: Italy Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Italy 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • UNITED KINGDOM
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 28: UK Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: UK 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • SPAIN
    • TABLE 30: Spain Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Spain 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • RUSSIA
    • TABLE 32: Russia Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Russia 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 34: Rest of Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Rest of Europe 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 36: Asia-Pacific Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Asia-Pacific 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • LATIN AMERICA
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 38: Latin America Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Latin America 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 40: Rest of World Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Rest of World 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030

IV. COMPETITION